Royal Bank of Canada cut its price target on Legend Biotech in a research report.
2 reports, 1 independent
Updated Aug 18
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada cut its price target on Legend Biotech in a research report.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Legend Biotech
Biotech company
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
Related events
- Royal Bank of Canada lowered its target price for Arthur J. Gallagher & Co. in a research report.
- Victory Capital, Royal Bank of Canada, and Morgan Stanley released research notes and raised price targets on August 12, 2026.
- Financial firms including Raymond James Financial, Citigroup, and Royal Bank of Canada adjusted price targets for EOG Resources, Inc. on July 9, 2026.
- Royal Bank of Canada cut its target price for Hecla Mining from $24.00 to $20.00 on September 18, 2026.
- An analyst report dropped the price objective for NanoXplore.